Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
10.49
+0.07 (0.67%)
Apr 10, 2026, 4:00 PM EDT - Market closed
Upstream Bio Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$37.67
Upside
+259.10%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades $40 → $15 | Buy → Hold | Downgrades | $40 → $15 | +42.99% | Mar 27, 2026 |
| Mizuho | Mizuho | Buy Initiates $51 | Buy | Initiates | $51 | +386.18% | Dec 18, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $40 | Buy | Initiates | $40 | +281.32% | Nov 18, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $47 | Strong Buy | Initiates | $47 | +348.05% | Oct 14, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $38 | Buy | Initiates | $38 | +262.25% | Nov 5, 2024 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 5, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Nov 5, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $75 | Buy | Initiates | $75 | +614.97% | Nov 5, 2024 |